View in EDS HTML Full Text PDF Full Text

Long-term patient experience with online MR-guided radiotherapy: adaptive versus non-adaptive workflow.

Saved in:
Bibliographic Details
Title: Long-term patient experience with online MR-guided radiotherapy: adaptive versus non-adaptive workflow.
Authors: Weykamp F; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Herder-Wagner C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Regnery S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Liermann J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hoegen-Saßmannshausen P; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Lang K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Renkamp CK; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Rippke C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Klüter S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany., Hörner-Rieber J; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Duesseldorf University Hospital, Duesseldorf, Germany.
Source: Frontiers in oncology [Front Oncol] 2026 Feb 03; Vol. 16, pp. 1700649. Date of Electronic Publication: 2026 Feb 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1700649